February 1, 2019
Hepatitis C Treatment - Update to pathway and claiming process
The Chronic Hepatitis C pathway has been updated for the newly funded direct acting antiviral (DAA) medication, Maviret™. Maviret™ is the recommended treatment in primary care for a majority of patients with Hepatitis C who do not have cirrhosis: Cure rate of 99%...
abscessECGcellulitisdvtTroponinACSAcute ECGantibioticBARTHOLIN'S ABSCESSboilBREAST ABSCESScephazolinChest PainCXRcystectopicFAQsFerinjectgynaeHep CHepatitisIVIV ironmaternityMaviretNurse AdvisorOSTovarianovarian cystovarian torsionpaediatric cellulitispelvic painpelvic scanpelvic ussPIDPOACPOAC ECGpoac pelvic\RivaroxabanSarah Hydersore throattonsilitiswells scoreXray